No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Leukemia, Myeloid, Acute* / therapy
-
Lymphocytes
-
Mutation
-
Prognosis
-
Sorafenib / therapeutic use
-
fms-Like Tyrosine Kinase 3
Substances
-
Sorafenib
-
fms-Like Tyrosine Kinase 3